The RESCUE 1-19 Trial: Radiation Eliminates Storming Cytokines and Unchecked Edema as a 1-Day Treatment for COVID-19
18 Years and older, Male and Female
This phase I / II trial studies how well low-dose radiation therapy works in treating patients with SARS or pneumonia associated with COVID-19 infection. The purpose of this study is to investigate the use of selectively localized low-dose radiation therapy in reducing pulmonary immuno-toxicity (lung damage) within viral pneumonia infiltrates in critically-ill patients with SARS-COVID-19.
I. To investigate clinical, radiographic, and immune outcomes in critically-ill patients with severe acute respiratory syndrome coronavirus disease 2019 (SARS-COVID-19) following whole-lung low-dose radiation therapy (LDRT).
Patients undergo 1 fraction of low-dose radiation therapy.
After completion of study treatment, patients are followed up at days 1-7, 14, 21, and 28 after last dose of intervention.
Treatment Sites in Georgia
**Clinical trials are research studies that involve people. These studies test new ways to prevent, detect, diagnose, or treat diseases. People who take part in cancer clinical trials have an opportunity to contribute to scientists’ knowledge about cancer and to help in the development of improved cancer treatments. They also receive state-of-the-art care from cancer experts... Click here to learn more about clinical trials